Globenewswire·2026-01-13 20:22Core Insights - Bragar Eagel & Squire, P.C. is investigating potential claims against Beyond Meat, Inc. and Alvotech for possible violations of federal securities laws and unlawful business practices [1] Beyond Meat, Inc. (NASDAQ:BYND) - On October 24, 2025, Beyond Meat announced an expected non-cash impairment charge for the three months ended September 27, 2025, related to certain long-lived assets, which was anticipated to be material [5] - Following this announcement, Beyond Meat's stock price dropped approximately 23%, from $2.84 per share on October 23, 2025, to $2.185 per share on October 24, 2025 [5] - On November 3, 2025, the company delayed its earnings announcement for Q3 2025 due to the need for additional time to complete the impairment review, leading to a significant decline in stock price during that trading day [5] Alvotech (NASDAQ:ALVO) - On November 3, 2025, Alvotech received a Complete Response Letter from the FDA regarding its AVT05 BLA biologics license application, following a failed facility inspection in July 2025 [5] - This news resulted in a stock price decline of $2.62, or 34.25%, closing at $5.03 per share [5]